← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 9, 2017Last known activity
Apr 2, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (7)
- NCT06778824Lead sponsorN/AApr 2, 2024
- NCT06778824Sponsor investigatorN/AApr 2, 2024
- NCT05094414Reponsible party - principal investigatorPhase 1Jul 1, 2021
- NCT05094414CollaboratorPhase 1Jul 1, 2021
- NCT05275647CollaboratorPhase 2May 18, 2021
- NCT04340765Overall official - principal investigatorN/AFeb 1, 2018
- NCT03343600CollaboratorPhase 2Nov 9, 2017
Details
- Last known activity
- Apr 2, 2024